VERTEX PHARMACEUTICALS INC (VX1.DE) Stock Earnings & Estimates
Europe - FRA:VX1 - US92532F1003 - Common Stock
349.225 EUR
+3.58 (+1.03%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 8.931B 17.91% | 9.869B 10.51% | 11.02B 11.66% | 12.224B 10.92% | 13.391B 9.55% | 14.6B 9.03% | 15.91B 8.97% | 17.547B 10.29% | 19.158B 9.18% | 19.91B 3.93% | 21.484B 7.91% | |
| EBITDA YoY % growth | 4.584B 57.66% | 4.54B -0.96% | 4.603B 1.37% | 5.544B 20.45% | 6.637B 19.72% | 7.277B 9.64% | 7.501B 3.08% | 8.155B 8.72% | 8.866B 8.72% | 9.49B 7.04% | 11.313B 19.21% | |
| EBIT YoY % growth | 4.436B 59.44% | 4.359B -1.73% | 4.396B 0.84% | 5.394B 22.72% | 6.301B 16.81% | 6.962B 10.49% | 7.513B 7.91% | 8.474B 12.79% | 9.098B 7.36% | 9.883B 8.63% | 10.875B 10.04% | |
| Operating Margin | 49.67% | 44.17% | 39.89% | 44.13% | 47.05% | 47.68% | 47.22% | 48.29% | 47.49% | 49.64% | 50.62% | |
| EPS YoY % growth | 14.89 14.36% | 15.22 2.22% | 0.29 -98.09% | 18.41 6,246.89% | 20.79 12.95% | 22.85 9.93% | 25.22 10.35% | 28.60 13.43% | 30.88 7.97% | 33.48 8.40% | 37.64 12.43% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 4.70 7.23% | 5.04 26.58% | 5.21 28.38% | 5.35 18.34% | 5.06 7.65% | 4.97 -1.40% |
| Revenue Q2Q % growth | 3.116B 12.41% | 3.272B 12.36% | 3.204B 15.66% | 3.315B 11.82% | 3.339B 7.16% | 3.378B 3.24% |
| EBITDA Q2Q % growth | 1.383B 7.04% | 1.556B 17.82% | 1.776B 64.86% | 1.698B 35.47% | 1.598B 15.55% | 1.4B -10.03% |
| EBIT Q2Q % growth | 1.395B 23.31% | 1.525B 36.96% | 1.586B 54.15% | 1.614B 39.95% | 1.556B 11.54% | 1.48B -2.95% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 4.52 135.23% | 4.37 | 0.15 | 3.45% |
| Q1 2025 Q2Q % growth | 4.06 -14.71% | 4.37 | -0.31 | -7.20% |
| Q4 2024 Q2Q % growth | 3.98 -5.24% | 4.11 | -0.13 | -3.07% |
| Q3 2024 Q2Q % growth | 4.38 7.35% | 4.22 | 0.16 | 3.69% |
| Q2 2024 Q2Q % growth | -12.83 -429.82% | 3.00 | -15.83 | -527.57% |
| Q1 2024 Q2Q % growth | 4.76 56.07% | 4.14 | 0.62 | 14.85% |
| Q4 2023 Q2Q % growth | 4.20 11.70% | 4.18 | 0.02 | 0.36% |
| Q3 2023 Q2Q % growth | 4.08 1.75% | 4.05 | 0.03 | 0.66% |
| Q2 2023 Q2Q % growth | 3.89 8.06% | 3.96 | -0.07 | -1.75% |
| Q1 2023 Q2Q % growth | 3.05 -13.35% | 3.06 | -0.01 | -0.21% |
| Q4 2022 Q2Q % growth | 3.76 11.57% | 3.58 | 0.18 | 4.95% |
| Q3 2022 Q2Q % growth | 4.01 12.64% | 3.72 | 0.29 | 7.89% |
| Q2 2022 Q2Q % growth | 3.60 15.76% | 3.55 | 0.05 | 1.44% |
| Q1 2022 Q2Q % growth | 3.52 18.12% | 3.56 | -0.04 | -1.18% |
| Q4 2021 Q2Q % growth | 3.37 34.26% | 3.37 | 0.00 | 0.13% |
| Q3 2021 Q2Q % growth | 3.56 34.85% | 3.14 | 0.42 | 13.27% |
| Q2 2021 Q2Q % growth | 3.11 19.16% | 2.56 | 0.55 | 21.59% |
| Q1 2021 Q2Q % growth | 2.98 16.41% | 2.74 | 0.24 | 8.66% |
| Q4 2020 Q2Q % growth | 2.51 47.65% | 2.64 | -0.13 | -5.00% |
| Q3 2020 Q2Q % growth | 2.64 114.63% | 2.39 | 0.25 | 10.49% |
| Q2 2020 Q2Q % growth | 2.61 107.14% | 2.12 | 0.49 | 23.38% |
| Q1 2020 Q2Q % growth | 2.56 124.56% | 1.88 | 0.68 | 36.03% |
| Q4 2019 Q2Q % growth | 1.70 | 1.23 | 0.47 | 38.03% |
| Q3 2019 Q2Q % growth | 1.23 | 1.17 | 0.06 | 4.95% |
| Q2 2019 Q2Q % growth | 1.26 | 1.09 | 0.17 | 15.76% |
| Q1 2019 Q2Q % growth | 1.14 | 0.99 | 0.15 | 14.85% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 2.965B 12.06% | 2.963B | 1.7M | 0.06% |
| Q1 2025 Q2Q % growth | 2.77B 2.96% | 2.91B | -139.8M | -4.80% |
| Q4 2024 Q2Q % growth | 2.912B 15.66% | 2.836B | 76M | 2.68% |
| Q3 2024 Q2Q % growth | 2.772B 11.61% | 2.778B | -6.1M | -0.22% |
| Q2 2024 Q2Q % growth | 2.646B 6.11% | 2.715B | -69.4M | -2.56% |
| Q1 2024 Q2Q % growth | 2.691B 13.30% | 2.63B | 60.6M | 2.30% |
| Q4 2023 Q2Q % growth | 2.518B 9.34% | 2.564B | -46.3M | -1.81% |
| Q3 2023 Q2Q % growth | 2.484B 6.39% | 2.55B | -66.5M | -2.61% |
| Q2 2023 Q2Q % growth | 2.493B 13.52% | 2.468B | 25.2M | 1.02% |
| Q1 2023 Q2Q % growth | 2.375B 13.22% | 2.384B | -9.2M | -0.39% |
| Q4 2022 Q2Q % growth | 2.303B 11.10% | 2.347B | -44.3M | -1.89% |
| Q3 2022 Q2Q % growth | 2.334B 17.65% | 2.271B | 63.3M | 2.79% |
| Q2 2022 Q2Q % growth | 2.196B 22.46% | 2.175B | 21.2M | 0.97% |
| Q1 2022 Q2Q % growth | 2.098B 21.64% | 2.118B | -20.5M | -0.97% |
| Q4 2021 Q2Q % growth | 2.073B 27.32% | 2.043B | 29.561M | 1.45% |
| Q3 2021 Q2Q % growth | 1.984B 28.99% | 1.893B | 91.164M | 4.82% |
| Q2 2021 Q2Q % growth | 1.793B 17.64% | 1.752B | 41.37M | 2.36% |
| Q1 2021 Q2Q % growth | 1.724B 13.81% | 1.69B | 34.305M | 2.03% |
| Q4 2020 Q2Q % growth | 1.628B 15.18% | 1.616B | 11.82M | 0.73% |
| Q3 2020 Q2Q % growth | 1.538B 61.95% | 1.515B | 23.271M | 1.54% |
| Q2 2020 Q2Q % growth | 1.524B 61.96% | 1.413B | 111.485M | 7.89% |
| Q1 2020 Q2Q % growth | 1.515B 76.50% | 1.313B | 202.107M | 15.39% |
| Q4 2019 Q2Q % growth | 1.413B | 1.033B | 380.265M | 36.81% |
| Q3 2019 Q2Q % growth | 949.828M | 969.92M | -20.092M | -2.07% |
| Q2 2019 Q2Q % growth | 941.293M | 903.29M | 38.003M | 4.21% |
| Q1 2019 Q2Q % growth | 858.435M | 867.48M | -9.045M | -1.04% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -0.4% | -0.38% | -0.15% | 0.44% |
| Revenue | 0.03% | 0.39% | -0.01% | 0.4% |